Work

After a median follow-up of 3.7 years, patients with low-risk thyroid cancer prepared for postoperative remnant ablation with either L-T 4 withdrawal or rhTSH stimulation have comparable rates of thyroid remnant ablation and tumor recurrence or persistent disease.